Loading company…
Tau Medical makes minimally invasive devices for treating tricuspid regurgitation, including the Pivot Extend and Pivot Bridge.
Tau-Medical Inc., trading as Tau Medical, was founded in 2014 and is headquartered in Busan, South Korea. It makes the Pivot-TR devices for tricuspid regurgitation: Pivot Extend, a permanent implant, and Pivot Bridge, a temporary device for frail or high-risk patients, both used without open-heart surgery. In September 2026 the company raised KRW 50 billion in pre-IPO funding from WONIK Investment Partners, Timefolio Asset Management, Vision Equity Partners and Loftyrock Investment, with returning investor Smilegate Investment also participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in